BioCentury
ARTICLE | Clinical News

Proteosome influenza vaccine: Phase I

April 30, 2001 7:00 AM UTC

Intellivax International Inc., Montreal, Quebec Product: Proteosome influenza vaccine Business: Infectious diseases Therapeutic category: Immune stimulation, Viral infection Target: Immune cells Descr...